Peter Jarcuska Selected Research

Peter Jarcuska Research Topics

Disease

6	Infections 01/2018 - 08/2004
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2023 - 06/2020
4	Hepatitis B 01/2018 - 03/2014
3	Liver Diseases (Liver Disease) 11/2021 - 08/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 03/2014
3	Chronic Hepatitis C 01/2018 - 07/2016
3	Obesity 01/2018 - 06/2013
2	Hemorrhage 11/2021 - 07/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2020 - 08/2010
2	Chronic Hepatitis B 07/2016 - 01/2016
2	Non-alcoholic Fatty Liver Disease 03/2014 - 08/2009
2	Abdominal Obesity 03/2014 - 06/2013
2	Hypertension (High Blood Pressure) 03/2014 - 01/2013
1	Neoplasms (Cancer) 01/2024
1	Liver Failure 01/2024
1	Dysbiosis 03/2023
1	COVID-19 01/2022
1	Thrombocytopenia (Thrombopenia) 11/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Inflammation (Inflammations) 10/2020
1	Disease Progression 06/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Persistent Infection 01/2018
1	Prediabetic State (Prediabetes) 01/2018
1	Diabetes Mellitus 01/2018
1	Portal Hypertension 07/2016
1	Hepatocellular Carcinoma (Hepatoma) 07/2016
1	Fibrosis (Cirrhosis) 07/2016
1	Esophageal and Gastric Varices (Esophageal Varices) 07/2016
1	Hepatorenal Syndrome 12/2015
1	Type 2 Diabetes Mellitus (MODY) 03/2014
1	Glucose Intolerance 03/2014
1	Overweight 03/2014
1	Muscular Diseases (Myopathy) 02/2013
1	Coronary Disease (Coronary Heart Disease) 01/2013
1	Ascites 12/2004

Drug/Important Bio-Agent (IBA)

4	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 10/2023 - 06/2020
4	InterferonsIBA 01/2022 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2023 - 08/2004
3	Immunoglobulin G (IgG)IBA 01/2020 - 03/2014
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 03/2014
3	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2014
3	CholesterolIBA 03/2014 - 12/2004
3	Triglycerides (Triacylglycerol)IBA 03/2014 - 08/2009
3	LDL CholesterolIBA 03/2014 - 06/2013
2	C-Reactive ProteinIBA 10/2020 - 03/2014
2	HDL LipoproteinsIBA 01/2018 - 03/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2016 - 02/2013
2	HDL CholesterolIBA 03/2014 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 03/2014 - 08/2010
2	oxidized low density lipoproteinIBA 03/2014 - 01/2013
1	Thrombopoietin ReceptorsIBA 11/2021
1	clonidine-displacing substance (ClDS)IBA 11/2021
1	Ferritins (Ferritin)IBA 10/2020
1	Alkaline PhosphataseIBA 06/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Ribavirin (Virazole)FDA LinkGeneric 07/2016
1	Interferon-alpha (Interferon Alfa)IBA 01/2016
1	CreatinineIBA 12/2015
1	SodiumIBA 12/2015
1	BilirubinIBA 12/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2014
1	DNA (Deoxyribonucleic Acid)IBA 03/2014
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2014
1	ApolipoproteinsIBA 03/2014
1	SmokeIBA 06/2013
1	SeleniumIBA 02/2013
1	UbiquinoneIBA 02/2013
1	coenzyme Q10 (CoQ10)IBA 02/2013
1	atorvastatin drug combination amlodipine FDA Link 01/2013
1	Peptidyl Transferases (Peptidyltransferase)IBA 08/2009
1	carbohydrate-deficient transferrinIBA 08/2009
1	Proteins (Proteins, Gene)FDA Link 12/2004
1	AlbuminsIBA 12/2004

Therapy/Procedure

4	Therapeutics 01/2024 - 01/2018
2	Liver Transplantation 01/2024 - 11/2021
2	Tattooing 01/2018 - 03/2014
1	Ligation 11/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Palliative Care (Palliative Therapy) 07/2016